Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Aug 6;71(9):1164–1170. doi: 10.1002/acr.23763

Table 3.

Statistical models evaluating the association between anti-RNPC3 positive systemic sclerosis patients and the presence of moderate to severe GI disease in the confirmatory study (University of Pittsburgh Scleroderma Center cohort)

Unadjusted Conditional Logistic
Model 1
Adjusted1 Conditional Logistic for Age and Race
Model 2
Adjusted2 Conditional Logistic for significant covariates
Model 3
Characteristic Odds Ratio 95% Confidence Interval Odds Ratio 95% Confidence Interval Odds Ratio 95% Confidence Interval
Significant GI dysfunction
 Medsger GI score <2 1.00 1.00 1.00
 Medsger GI score ≥2 3.84 1.50 – 9.83 3.79 1.43 – 10.02 3.81 1.02 – 14.28
Race
 Non-African American 1.00 1.00 1.00
 African American 3.58 1.11 – 11.48 2.36 0.65 – 8.54 5.59 0.64 – 48.7
Diffuse cutaneous disease 1.61 0.80 – 3.25 - - 1.90 0.75 – 4.78
Interstitial lung disease (ILD) 5.85 2.33 – 14.65 - - 2.79 0.95 – 8.19
Myopathy 0.36 0.08 – 1.61 - - 0.07 0.01 – 0.75
Age at Visit 1 0.97 0.95 – 1.00 0.97 0.95 – 1.00 0.97 0.94 – 1.01

GI = gastrointestinal;

1.

Adjusted conditional logistic regression model, adjusted for age and race;

2.

Adjusted conditional logistic regression model, adjusted for age and race, ILD, Diffuse cutaneous disease, Myopathy. Those covariates were selected by backwards selection.